Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less ...

Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Chen recommended a minimally invasive procedure that uses heat to target the remaining tumor cells. This technique, done in ...

"For example, CAR-T 19 targets CD19 on every B cell, but the EGF receptor mutations that we're targeting in glioblastoma are ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

A study from Lund University identifies foam cells in glioblastoma patients, revealing their role in promoting tumor growth.

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

By converting immunologically 'cold' tumours into 'hot' ones, MB-108 may enhance the efficacy of the MB-101 CAR-T cell ...